In the United States (US), a silent but deadly crisis rages.
The culprit, fentanyl, a synthetic opioid, wreaks havoc far beyond its size.
With over 72,000 lives lost in 2022 alone, it's a national emergency rooted in international trade.
At the heart of this storm is China, the primary source of illicit fentanyl infiltrating American streets.
Fentanyl, up to 60 times stronger than morphine, was initially a medical marvel for pain relief. However, its illicit analogues, concocted in clandestine labs, pack a punch up to 10,000 times more potent than morphine.
These synthetic combinations are what the streets see — cheap to produce, easy to hide, and tragically easy to overdose on.
The US witnessed a shocking 45 per cent surge in synthetic opioid deaths between 2016 and 2017, underscoring the urgency of the situation.
China emerges as the epicentre of this crisis, not as a direct aggressor, but as a negligent enforcer.
Lax oversight and prioritisation of economic growth have turned the country into a breeding ground for fentanyl production.
Chinese chemical firms, exploiting regulatory loopholes, have flooded the US market with fentanyl and its precursors.
By cleverly mislabelling shipments or re-routing them through other countries, these firms evade detection, fuelling America's opioid epidemic.
In response, the US has taken a firm stand, indicting Chinese companies and executives for their complicity. However, China's response has been one of deflection, often labelling US accusations as scapegoating.
In an effort to stem the tide, the US enacted the STOP Act in 2018, mandating advanced information for international postal shipments.
Despite such measures, the challenge persists. The international nature of the crisis, involving both China as the supplier and Mexico as a key transit point, complicates US efforts.
Successive US administrations have struggled to engage China constructively on this issue.
The geopolitics of US-China relations, often strained, have hindered meaningful cooperation in narcotics control. China's recent withdrawal from counternarcotics cooperation with the US in 2022 marked a significant setback.
The human cost in the US is staggering. Over a million Americans have fallen victim to drug overdoses since 1999, with fentanyl playing a leading role.
The economic burden is equally crushing, with opioid overdoses inflicting approximately $1 trillion annually.
As the fentanyl crisis continues to devastate American communities, the need for international cooperation and effective strategy is more pressing than ever before.
While the US grapples with this complex issue, the resolution requires a concerted effort, transcending national boundaries and political differences.
The invisible invasion of fentanyl, a grim reminder of globalisation's dark side, demands a response as potent as the drug itself.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.